The Expression of Peripheral Blood CD36 and Its Clinical Significance in Patients with Chronic Kidney Disease
方燕,张俞,钱家麒,戴慧莉,王琴,牟珊,倪兆慧,严玉澄
DOI: https://doi.org/10.3969/j.issn.1671-4091.2012.02.003
2012-01-01
Abstract:Objective To investigate the expression of peripheral blood CD36 level,its influence factors,and its clinical significance in patients with chronic kidney disease.Methods A total of 77 chronic kidney disease (CKD) patients and 10 healthy subjects were included in this study.Clinical data was collected.Blood tests,echocardiogram and carotid artery ultrasound were taken.The number of CD36+ cells in whole blood was determined by a flow cytometer and compared among patients with CKD stage 1～3,Stage 4～5 and healthy subjects.Its correlations with lipid,inflammation indices,carotid plaques and left ventricular hypertrophy were analyzed.Results The CD36+ level was significantly higher in patients at CKD stage 1～3 and CKD stage 4～5 than in control subjects [(476.73±191.41)×105/L,(1463.61±592.90)×105/L and (68.55±12.73)×105/L,respectively,P0.01],and was significantly higher in patients at CKD stage 4～5 than in patients at CKD stage 1～3 (P0.01).The CD36+ level was significantly higher in patients with left ventricular hypertrophy than in those without left ventricular hypertrophy [(1255.07±704.20)×105/L vs (805.34±586.20)×105/L,P0.05].Multiple regression analysis showed that the CD36+ level in whole blood was an independent risk factor for carotid artery plaque (β=0.295,P=0.010).Multiple linear regression analysis showed that eGFR (β-0.301,P0.01) and triglyceride (β-0.294,P0.01) were the stronger independent determinants of the CD36+ level.Conclusion The CD36+ level in whole blood was elevated in CKD patients.The increase of CD36+ level was closely associated with renal function deterioration and dyslipidemia,and might relate to left ventricular hypertrophy and atherosclerosis.